GENE ONLINE|News &
Opinion
Blog

Biologics
Special Biologics
A Force To Be Reckoned With – BioBetter Biologics
2022-12-14
Trials & Approvals Eczema
FDA OKs First Biologic for Children Under 5 With Moderate-to-Severe Atopic Dermatitis
2022-06-08
Deals AI
Amgen Taps Generate to Discover Multi-Target Protein Drugs in $1.9+ Billion Deal
2022-01-07
Funding Small Molecule Drug
ShouTi Raises $100M in Series B to “Replace Biologic Injections with Pills”
2021-10-21
Biosimilar
Addressing The Global Need for Biosimilars: Current Trends, Expectations and Real World Experiences
2021-08-26
GenScript’s Biotech Unit, ProBio Bags $150 Million in Series A from Hillhouse Capital
2021-08-20
Asia-Pacific Oncology
China’s BeiGene to Build a Biologics Manufacturing Site in the US
2021-08-04
COVID-19 Favilavir
Weekly Cover: Taiwan Synthesizes Potential COVID-19 Treatment Favilavir
2020-03-04
LATEST
Ginkgo Bioworks and Pfizer Forge $331 Million Collaboration for RNA-Based Drug Discovery
2023-09-29
Johnson & Johnson Partners with Singapore to Boost Life Sciences Innovation
2023-09-28
Vietnam and South Korea Strengthen Cooperation in Multiple Sectors
2023-09-27
PeptiDream and Genentech Collaborate on Novel Peptide-Radioisotope Drug Conjugates
2023-09-27
AcuraStem and Takeda Collaborate on Innovative ALS Treatment
2023-09-27
Seven AI/ML for Life Sciences Companies Identified as Innovators in New Clarivate Companies to Watch Report
2023-09-27
GeneOnline’s Weekly News Highlights: Sept 17-Sept 22
2023-09-26
READ MORE
EVENT
2023-10-04
BioFuture 2023
New York city,USA
2023-11-16
3rd INTERNATIONAL CONFERENCE ON NUTRITION AND HEALTHCARE
Dubai, UAE
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2023 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top